News
Atherotech Diagnostics Lab opened its patient service center in Sarasota, Fla.
March 27, 2014
Technology
The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for three new digital angiography systems from Shimadzu Medical Systems. These are the ceiling-mounted Trinias, the floor-mounted Trinias, and the Biplane models.
March 27, 2014
News
Manhattan Scientifics announced a collaboration with Azano Biotech that will make NanoMRX Precision Nanoparticles available for purchase.
March 26, 2014Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature
InspireMD Inc. has enrolled the first patient into the CARENET (CARotid Embolic protection study using microNET) multi-center European clinical trial for the new CGuard carotid embolic protection system.
March 26, 2014
News
Based on its recent analysis of the superconductor technology for MRI market, Frost & Sullivan recognizes Cutting Edge Superconductors, Inc. with the 2013 North American Frost & Sullivan Award for Technology Innovation Leadership.
March 26, 2014
Technology
St. Jude Medical Inc. has received approval from the U.S. Food and Drug Administration (FDA) for the Allure Quadra Cardiac Resynchronization Therapy Pacemaker (CRT-P), which provides additional pacing innovations for physicians to treat patients with heart failure (HF). The company also announced FDA approvals for the Assurity pacemaker and Endurity pacemaker families of devices.
March 26, 2014Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News
Aerotel Medical Systems has received the CE Mark approval for its new electrocardiogram (ECG) devices, HeartView P12/8i and HeartView 12L.
March 25, 2014
Feature
Biotronik has announced the Food and Drug Administration (FDA) has approved the expansion of Biotronik’s ongoing ProMRI clinical trial. The new phase of the trial (Phase C) will study the company’s ProMRI technology in implantable cardioverter-defibrillator (ICD) devices. Biotronik is the only company in the world with an ICD that is approved for investigational use in a magnetic resonance imaging (MRI) scanner. The ongoing ProMRI study is the first step in making this standalone technology available in the United States.
March 25, 2014
Technology
The NDS Surgical Imaging (NDSsi) Dome S6c diagnostic display is a 6-megapixel (MP) LED widescreen model, and the latest addition to the S-series product family. It features 30-inch widescreen viewing, can be utilized as a single 6 MP or in dual 3 MP bezel-free format and provides both grayscale and color images. A native resolution of 3,280 by 2,048 makes it ideal for viewing a wide range of medical imaging modalities including computed radiography (CR), digital radiography (DR), magnetic resonance (MR), computed tomography (CT), positron emission tomography/computed tomography (PET/CT), ultrasound and 3-D volume rendering. Offering 800cd/m² high-bright LED-backlight technology and 1,000:1 contrast ratio, the Dome S6c delivers a new benchmark in optical clarity and image brilliance in varying ambient light environments.
March 25, 2014Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News
As long as inexpensive statins, which lower cholesterol, are readily available and patients do not mind taking them, it does not make sense to do a heart comuted tomography (CT) scan to measure how much plaque has built up in a patient’s coronary arteries before prescribing the pills, according to a new study by researchers at UC San Francisco.
March 25, 2014News
Patient enrollment has been completed four months ahead of plan in the Phase III clinical trial EUCLID study for AstraZeneca's ticagrelor (Brilinta) tablets. Part of PARTHENON, AstraZeneca’s largest clinical trial program, EUCLID has randomized more than 13,500 patients globally with peripheral artery disease (PAD); approximately 20 percent are patients in the United States from more than 300 active clinical trial sites across the country. EUCLID is designed to evaluate the effects of ticagrelor (monotherapy) compared to clopidogrel (monotherapy) on cardiovascular (CV) events and safety in PAD patients. Ticagrelor is currently not approved for the treatment of patients with PAD.
March 25, 2014
Feature
UC Davis clinicians and physicists have recommended new strategies to make computed tomography (CT) safer, including adoption of a new metric for dose measurement, ways to manage exposure protocols that differ by CT brand and specific approaches to reduce exposure during needle biopsies.
March 25, 2014Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023Technology
Digisonics will showcase its upcoming DigiView Release 3.8.4. for its Cardiovascular Information System (CVIS) at this year’s American College of Cardiology (ACC) annual scientific session in Washington, D.C., March 28-31.
March 25, 2014
Feature
Computed tomography (CT) imaging utilization has grown markedly across many clinical disciplines during the past decade, raising concerns about radiation overexposure.
March 24, 2014Technology
Health Level announced the availability of Foundations Cardiology, a packaged solution that increases the speed and agility for cardiology centers by blending data from multiple applications and extending the role of the data warehouse to include real-time data analytics.
March 24, 2014© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now